# Incresync · 12,5 mg + 30 mg · Tabletki powlekane · 90 tabl.



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `89389`
- **eu-number** — `EU/1/13/842/007`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Takeda Pharma A/S

## Proof

Record pl:presentation:89389 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Incresync 12.5 mg - 30 mg](https://dosidal.ai/pack/be/447297-01) — BE — same product (EU central number)
- [INCRESYNC](https://dosidal.ai/pack/cz/0194466) — CZ — same product (EU central number)
- [Incresync](https://dosidal.ai/pack/eu/EU-1-13-842-007) — EU — same product (EU central number)
- [INCRESYNC 12,5 MG/30 MG FILMTABLETTA](https://dosidal.ai/pack/hu/210675639) — HU — same product (EU central number)
- [Incresync 12,5 mg/30 mg filmom obalené tablety](https://dosidal.ai/pack/sk/7302A) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
